📢 Just published! BIG’s Patient Partnership shows how people with lived experience can shape global breast cancer research. 🎀🌍 A model for research with patients, not just for them. BIG thank you to our patient partners! 💞 doi.org/10.1016/j.br...

#APHINITY: LBA1 - The final overall survival analysis with a median follow-up 11.3 years will be presented at #ESMOBreast25 by @LoiblSibylle. Join us tomorrow at 15:00 in the Proffered Paper Session, room 14. @JulesBordet @IEOufficiale FSS

The growing impact of climate change 🔥🌪️⛈️🌊☀️ on how we conduct trials & the multiple opportunities for ♻️sustainability in our community. Grateful to 🏴󠁧󠁢󠁷󠁬󠁳󠁿🇬🇧🇧🇪🇮🇪🇸🇪🇬🇷🇧🇷🏴󠁧󠁢󠁳󠁣󠁴󠁿 co authors & @bigxresearch.bsky.social members who completed the survey

The #AURORA Data Analysis Committee is in Florence for a “datathon”! Over the next 2 days, PIs, bioinformaticians, clinicians, and BIG HQ are working together on analyses to advance a new AURORA manuscript. @aftimosp.bsky.social @elisaagostinetto.bsky.social

Congratulations Siobhan! 🌟Wonderful to see recognition for all your work on the patient-led survey of patients with metastatic #breastcancer in Ireland!!

🚨 The final analysis of the phase 3 #ALEXANDRA/IMpassion030 study on adding atezolizumab to post-op chemo for high-risk early-stage #TNBC is out in @jama.com, contributing to a greater understanding of immunotherapy in #breastcancer👉 jamanetwork.com/journals/jam... @mignatiadis.bsky.social